Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

36.29
-1.7400-4.58%
Post-market: 36.290.00000.00%16:38 EDT
Volume:671.95K
Turnover:24.65M
Market Cap:1.95B
PE:-18.03
High:38.39
Open:37.72
Low:36.18
Close:38.03
52wk High:39.15
52wk Low:6.42
Shares:53.87M
Float Shares:17.22M
Volume Ratio:0.65
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0125
EPS(LYR):-2.0125
ROE:-39.83%
ROA:-25.68%
PB:7.54
PE(LYR):-18.03

Loading ...

Tyra Biosciences FY2026 director Gilla Kaplan disposes of common shares; value drops to $3,950,000

Reuters
·
12 hours ago

Tyra Bioscience Insider Trade Sparks Fresh Buzz Around the Stock

TIPRANKS
·
7 hours ago

Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Performance

Simply Wall St.
·
Mar 23

Boone Capital Backs Tyra Biosciences As FGFR3 Trials Shape Outlook

Simply Wall St.
·
Mar 21

Tyra Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Mar 20

Tyra Bioscience (TYRA) Receives a Buy from Piper Sandler

TIPRANKS
·
Mar 20

Tyra Biosciences Inc : Piper Sandler Raises Target Price to $56 From $42

THOMSON REUTERS
·
Mar 20

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

TIPRANKS
·
Mar 11

Stock Track | Tyra Biosciences Plummets 6.58% Intraday on Negative Analyst Commentary

Stock Track
·
Mar 05

Tyra Bioscience Raises $126 Million in Block Share Sale

TIPRANKS
·
Mar 05

BRIEF-Tyra Biosciences Agreed To Issue 4 Million Shares At $31.50 Per Share To A Large Investment Management Firm - SEC Filing

Reuters
·
Mar 05

Tyra Biosciences- Agreed to Issue 4 Mln Shares at $31.50 per Share to a Large Investment Management Firm - SEC Filing

THOMSON REUTERS
·
Mar 05

Tyra Biosciences Inc - Expects $126.0 Mln in Gross Proceeds From Share Sale - SEC Filing

THOMSON REUTERS
·
Mar 05

Tyra Bioscience (TYRA) Gets a Buy from Piper Sandler

TIPRANKS
·
Mar 03

Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward

TIPRANKS
·
Mar 03

Analysts’ Top Healthcare Picks: Stryker (SYK), Tyra Bioscience (TYRA)

TIPRANKS
·
Mar 03

Tyra Biosciences reports Q4 EPS (57c), consensus (53c)

TIPRANKS
·
Mar 03

Tyra Biosciences Q4 EPS $(0.57) Misses $(0.55) Estimate

Benzinga
·
Mar 03

Tyra Biosciences Q4 net loss widens on higher R&D costs

Reuters
·
Mar 03

Tyra Q4 net loss hits USD 33.8 million, up 32.3%

Reuters
·
Mar 03